For most people with arthritis, oral anti-inflammatory drugs like ibuprofen and naproxen provide the strongest over-the-counter pain relief. In head-to-head comparisons, NSAIDs reduce both resting and walking pain significantly more than acetaminophen (Tylenol), with an advantage of about 6 points on a 100-point pain scale. But “most effective” depends heavily on your type of arthritis, which joints hurt, and what other health conditions you have. The best painkiller for a 40-year-old with a sore knee is not the same as the best option for a 70-year-old with rheumatoid arthritis and kidney problems.
Why NSAIDs Outperform Acetaminophen
Arthritis pain is driven largely by inflammation, and that’s where NSAIDs have an edge. Acetaminophen blocks pain signals but does almost nothing to reduce inflammation in the joint itself. A meta-analysis of seven clinical trials found that NSAIDs reduced pain at rest by about 6 mm more than acetaminophen on a standard 100-point pain scale, with a similar advantage for walking pain. That gap may sound modest on paper, but for people living with daily stiffness and soreness, it often translates to noticeably better function.
The safety profiles were closer than many people assume. Withdrawal rates due to side effects were not significantly different between the two drug classes in those trials. That said, long-term NSAID use carries real risks that acetaminophen largely avoids, which is why acetaminophen still has a role for people who can’t tolerate anti-inflammatories.
Choosing Between Different NSAIDs
Not all NSAIDs are created equal. The major split is between traditional options (ibuprofen, naproxen, diclofenac) and selective COX-2 inhibitors like celecoxib, which were designed to be gentler on the stomach.
In a randomized trial comparing celecoxib to high-dose ibuprofen for knee osteoarthritis, celecoxib matched ibuprofen’s pain relief while causing fewer upper gastrointestinal problems: just 1.3% of celecoxib users reported significant stomach issues compared to 5.1% on ibuprofen. Celecoxib also outperformed ibuprofen on stiffness and patient satisfaction. About 71% of celecoxib users said their medication made daily activities easier, compared to 62% on ibuprofen.
Among traditional NSAIDs, naproxen stands out for one reason: it appears to be the safest for your heart. A large meta-analysis of individual patient data found that naproxen did not significantly increase the risk of major cardiovascular events or vascular death. Diclofenac and COX-2 inhibitors, by contrast, raised the risk of major vascular events by roughly 37 to 41%. Ibuprofen more than doubled the risk of major coronary events. For anyone with existing heart disease or elevated cardiovascular risk, naproxen is typically the preferred NSAID.
Long-Term NSAID Risks Worth Knowing
All NSAIDs roughly double the risk of hospitalization for heart failure, regardless of type. Upper gastrointestinal bleeding risk varies sharply: naproxen and ibuprofen increase the rate of serious GI complications by roughly four times compared to placebo, while COX-2 inhibitors and diclofenac increase it by about 1.8 to 1.9 times. For every 1,000 people taking a COX-2 inhibitor or high-dose diclofenac for a year, roughly seven or eight additional major vascular events would occur, two of them fatal.
Older adults face compounded risks. High-dose NSAID use is associated with a 26% increased risk of worsening kidney disease. If you have chronic kidney problems, liver disease, or a history of stomach ulcers, your options narrow considerably, and topical treatments or non-NSAID alternatives become more important.
Topical Painkillers for Localized Pain
If your pain is concentrated in one or two joints, particularly the knees or hands, topical anti-inflammatories can be surprisingly effective while largely avoiding the systemic risks of pills. Topical diclofenac gel delivers the drug directly to the joint, and meta-analyses show it provides significant pain relief that actually grows over time. At three to six weeks, topical diclofenac showed large effect sizes compared to placebo, and the benefit continued to increase through 8 to 12 weeks of use.
The safety advantage is clear. Topical diclofenac showed no significant increase in gastrointestinal side effects compared to placebo, with identical event rates between the two groups. Skin reactions like mild redness or dryness can occur, but even these were not statistically more common with the gel formulation than with placebo.
Capsaicin cream, derived from chili peppers, works differently. It depletes a chemical in nerve endings that transmits pain signals. Higher-strength formulations (0.25%) work fast: 55% of patients experienced at least a 50% reduction in pain after just two days. Lower-strength versions (0.025%) took about two weeks to reach the same threshold. The initial burning sensation puts some people off, but it fades with consistent use.
When Arthritis Pain Needs More Than Painkillers
For rheumatoid arthritis, painkillers alone are the wrong strategy. NSAIDs and steroids relieve symptoms but do nothing to stop the immune system from destroying joint tissue. Disease-modifying drugs, including methotrexate and newer biologic therapies, slow or halt the underlying damage. Research shows that younger patients who start biologic therapy early (within about two years of diagnosis) can reduce their need for steroids and painkillers by more than 50%.
A newer class of oral medications, JAK inhibitors, has shown particular promise for pain. In head-to-head comparisons with biologic therapies that target a specific inflammatory protein called TNF, JAK inhibitors produced an additional 4 mm decrease in pain scores at three months. They were at least as effective as other biologic options for pain relief. These are prescription medications reserved for moderate to severe rheumatoid arthritis, typically after other treatments have been tried.
Antidepressants as Arthritis Pain Treatment
This sounds counterintuitive, but a specific type of antidepressant that affects pain-processing pathways in the brain and spinal cord has proven effective for osteoarthritis pain. Duloxetine, taken at 60 mg daily, produced a moderate but consistent reduction in pain across five clinical trials involving over 1,700 participants. The benefit was maintained over 12 to 14 weeks of follow-up. This option is particularly useful for people who can’t take NSAIDs due to kidney, heart, or stomach concerns, or whose pain has a widespread, sensitized quality that suggests the nervous system itself is amplifying pain signals.
Special Considerations for Older Adults
Pain management gets more complicated with age because the body processes drugs differently and the risk of side effects climbs. Acetaminophen is often tried first, but the maximum safe dose drops from 4 grams to 2 or 3 grams per day for people who are malnourished, drink alcohol regularly, or have any liver problems.
Opioid-based painkillers carry particular hazards in older adults. The body becomes more sensitive to their sedating effects with age, increasing fall risk. Certain opioids should be avoided entirely: meperidine can cause seizure-like toxicity as its byproducts accumulate, methadone’s long duration of action makes dosing unpredictable, and codeine and tramadol rely on a liver enzyme that varies wildly between individuals and is blocked by many common medications.
For many older adults, topical NSAIDs offer the best balance of meaningful pain relief with minimal systemic risk. When that’s not enough, the choice between oral NSAIDs, duloxetine, or other options depends on which organ systems are most vulnerable. Someone with heart disease but a healthy stomach might do well on naproxen. Someone with kidney problems might be better served by acetaminophen plus topical treatment. There is no single most effective painkiller for arthritis; there is only the most effective one for your particular body.